Yüklüyor......
Current Status and Future Targeted Therapy in Adrenocortical Cancer
Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. The current treatment standards include complete surgical resection for localized resectable disease and systemic therapy with mitotane alone or in combination with etoposide, doxorubicin, and cisplatin in patients with advan...
Kaydedildi:
| Yayımlandı: | Front Endocrinol (Lausanne) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957049/ https://ncbi.nlm.nih.gov/pubmed/33732213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.613248 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|